Top

Advent – Acquisition of Evonik’s methacrylates business

Global private equity firm Advent has agreed to buy Evonik’s methacrylates business lines in a carve-out deal valued at around €3b. The transaction comprises the methacrylates, acrylic products and CyPlus business lines, and some of the methacrylate resins activities. Evonik’s methacrylates business has 18 production sites and 3,900 employees worldwide.